✦ LIBER ✦

Bevacizumab and ranibizumab for neovascular age-related macular degeneration: a treatment approach based on individual patient needs

✍ Scribed by Bellerive, Claudine; Cinq-Mars, Benoît; Lalonde, Gilles; Malenfant, Mario; Tourville, Éric; Tardif, Yvon; Giasson, Marcelle; Hébert, Marc

Book ID: 123037958
Publisher: Canadian Ophthalmological Society
Year: 2012
Tongue: English
Weight: 180 KB
Volume: 47
Category: Article
ISSN: 0008-4182
DOI: 10.1016/j.jcjo.2012.01.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ranibizumab treatment administered as ne

Ranibizumab treatment administered as needed for occult and minimally classic neovascular membranes in age-related macular degeneration

✍ Seungbum Kang; Young-Jung Roh 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 162 KB

Intravitreal Bevacizumab for Treatment o

Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: A One-year Prospective Study

✍ Ziad F. Bashshur; Zeina A. Haddad; Alexandre Schakal; Rola F. Jaafar; Marc Saab; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 655 KB

A randomised double-masked trial compari

A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration

✍ Krebs, I.; Schmetterer, L.; Boltz, A.; Told, R.; Vecsei-Marlovits, V.; Egger, S. 📂 Article 📅 2013 🏛 BMJ Publishing Group 🌐 English ⚖ 251 KB

Patient Preferences Regarding Monitoring

Patient Preferences Regarding Monitoring and Treatment for the Management of Neovascular Age-Related Macular Degeneration

✍ Ferreira, A.; Lall, A.; Squire, A.; Gregg, L.; Graham, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PSS11 Ranibizumab and Bevacizumab for th

PSS11 Ranibizumab and Bevacizumab for the Treatment of Age-related Macular Degeneration: A Systematic Review and Economic Evaluation

✍ Martinez Ferez, I.M.; Flores Moreno, S. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Intravitreal bevacizumab (Avastin) for n

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration using a variable frequency regimen in eyes with no previous treatment

✍ Kenneth CS Fong; Nigel Kirkpatrick; Quresh Mohamed; Robert L Johnston 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB